TACR1 and cancer: The fl-NK-1R isoform promoted a slow growth of cancer cells, whereas the tr-NK-1R form increased the growth of tumor cells, mediated malignancy in cancer cells, and stimulated the synthesis of cytokines which exert growth-promoting actions [21].